August 21, 2017August 21, 2017
Survey to Study How Blood Type Affects Risk in Autoimmune Diseases Seeking AS Patients

A large-scale survey is underway for patients with a definite diagnosis of ankylosing spondylitis and who know their blood ... Read more
August 18, 2017August 18, 2017
AS More Severe in Blacks Than in Whites or Latinos in US, Study Finds

African-Americans are more likely to develop severe ankylosing spondylitis (AS), with greater loss of function and higher disease activity, ... Read more
July 26, 2017July 26, 2017
Renflexis, a Remicade Biosimilar, Is Now Available in the US

Renflexis (infliximab-abda), a biosimilar of Remicade (infliximab), is now available in the United States for the treatment of ... Read more
July 24, 2017July 24, 2017
Statins’ Dual Effect May Extend Survival of Ankylosing Spondylitis Patients, Study Finds

Cholesterol-lowering medications called statins may lower mortality rates in patients with ankylosing spondylitis more efficiently than in the general population, ... Read more
July 21, 2017July 21, 2017
Australian Receives NHMRC Award for Genomic Research on Ankylosing Spondylitis

The National Health and Medical Research Council (NHMRC) in Australia awarded five researchers at the University of Queensland for their ... Read more
July 20, 2017July 20, 2017
European Commission Approves Sandoz Biosimilar Erelzi to Treat Various Inflammatory Diseases

The European Commission recently approved Erelzi, a biosimilar etanercept drug manufactured by the Sandoz division of Switzerland’s Novartis, for all therapeutic ... Read more
July 17, 2017July 17, 2017
Imraldi, a Humira Biosimilar Candidate, Receives Positive Review from European Panel

Imraldi, an investigative biosimilar product to Humira (adalimumab), received a positive review from the Committee for Medicinal Products for ... Read more
July 13, 2017July 13, 2017
Smoking Doubles Risk of Spinal Damage in Ankylosing Spondylitis Patients, Study Finds

Patients with ankylosing spondylitis (AS) who smoke are twice as likely to have cumulative spinal structural damage, according to ... Read more
July 12, 2017July 12, 2017
Cosentyx Improved Symptoms of Ankylosing Spondylitis, Psoriatic Arthritis

Novartis recently announced that its leading drug Cosentyx (secukinumab) improves both signs and symptoms of active ankylosing spondylitis (AS), according ... Read more

Survey to Study How Blood Type Affects Risk in Autoimmune Diseases Seeking AS Patients

A large-scale survey is underway for patients with a definite diagnosis of ankylosing spondylitis and who know their blood type. The survey will allow researchers to determine whether blood ... Read more

August 18, 2017August 18, 2017

AS More Severe in Blacks Than in Whites or Latinos in US, Study Finds

African-Americans are more likely to develop severe ankylosing spondylitis (AS), with greater loss of function and higher disease activity, than either white Americans or Latinos, a new study revealed. ... Read more

July 26, 2017July 26, 2017

Renflexis, a Remicade Biosimilar, Is Now Available in the US

Renflexis (infliximab-abda), a biosimilar of Remicade (infliximab), is now available in the United States for the treatment of ankylosing spondylitis and other conditions. The launch was recently announced by Samsung Bioepis as the ... Read more

July 24, 2017July 24, 2017

Statins’ Dual Effect May Extend Survival of Ankylosing Spondylitis Patients, Study Finds

Cholesterol-lowering medications called statins may lower mortality rates in patients with ankylosing spondylitis more efficiently than in the general population, new research suggests. The study, “Survival benefit of statin use ... Read more

July 21, 2017July 21, 2017

Australian Receives NHMRC Award for Genomic Research on Ankylosing Spondylitis

The National Health and Medical Research Council (NHMRC) in Australia awarded five researchers at the University of Queensland for their work in several medical fields. One of the awardees, professor David ... Read more

July 20, 2017July 20, 2017

European Commission Approves Sandoz Biosimilar Erelzi to Treat Various Inflammatory Diseases

The European Commission recently approved Erelzi, a biosimilar etanercept drug manufactured by the Sandoz division of Switzerland’s Novartis, for all therapeutic indications of its reference medicine Enbrel (etanercept), including ankylosing spondylitis. ... Read more

July 17, 2017July 17, 2017

Imraldi, a Humira Biosimilar Candidate, Receives Positive Review from European Panel

Imraldi, an investigative biosimilar product to Humira (adalimumab), received a positive review from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) as ... Read more

July 13, 2017July 13, 2017

Smoking Doubles Risk of Spinal Damage in Ankylosing Spondylitis Patients, Study Finds

Patients with ankylosing spondylitis (AS) who smoke are twice as likely to have cumulative spinal structural damage, according to preliminary results of a systematic review study conducted by researchers ... Read more

July 12, 2017July 12, 2017

Cosentyx Improved Symptoms of Ankylosing Spondylitis, Psoriatic Arthritis

Novartis recently announced that its leading drug Cosentyx (secukinumab) improves both signs and symptoms of active ankylosing spondylitis (AS), according to the results of a three-year Phase 3 extension trial ... Read more